We are excited to announce that our President and CEO Ellen Matloff has been invited to be a panelist at the FDA’s upcoming March 2 public workshop titled “Patient and Medical Professional Perspectives on the Return of Genetic Test Results.” She will speak on...
On July 10, 2015, the House of Representatives approved the 21st Century Cures Act (H.R. 6) with a vote of 344-77. This act will launch healthcare into the 21st century by “investing in science and medical innovation, incorporating the patient perspective, and...
A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time, at more than $4,000 a pop, in order to qualify for a new drug called...
